Brain Implants Market, By Product Type (Deep Brain Stimulator, Spinal Cord Stimulator, and Others), By Application (Chronic Pain, Epilepsy, Parkinson’s Disease, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI102019 | Publish Date: February 2024 | No. of Pages: 170

Global Brain Implants Market By Overview

Brain Implants Market was valued at US$ 6.4 Billion in 2024 and is projected to grow at a CAGR of 12.70% to reach US$ 19 Billion by 2034.

Brain implants, often referred as neural implants, are the devices that are connected directly to the brain. These brain implants are placed on the brain surface i.e., over gyri and sulci, or they are attached to the cortex of brain. Brain implants are implanted when brain becomes dysfunction due to various reasons such as head injuries and stroke. The brain implants are primarily inserted into the brain to enhance physical movement, memory, and sensitivity. Brain implants are extensively utilized on animals for scientific research purpose. 

Global Brain Implants Market By Drivers & Restraints

    

Factor driving growth of the global brain implants market is high prevalence of neurological disorders such as Parkinson’s and Alzheimer’s diseases, epilepsy, depression, and essential tremor among all age groups across the globe. For instance, according to a study conducted by the Alzheimer’s Association, approximately 476,000 people aged 65 or more in the United States developed Alzheimer’s disease in 2016. As reported by the Alzheimer’s Society, the number of people with dementia in the United Kingdom increased from 815,827 in 2013 to 856,700 in the year 2015. In addition, rising support from the government authorities and various healthcare organizations to improve overall healthcare infrastructure in emerging countries is propelling growth of the target market. Furthermore, increase in skilled healthcare professionals to provide the treatment is another key factor expected to fuel growth of the target market. Moreover, growing brain implant surgery treatment among geriatric population across the globe to treat neurological disorders and other age-related diseases and disorders is expected to boost growth of the global market over the forecast period.

Additionally, rising awareness about the technologically advanced brain implant devices among individuals across the globe is presumed to propel growth of the global market. However, high initial and maintenance cost of brain implant devices and lack of awareness about brain implants among individuals in emerging countries of the globe are restraining the growth of the global brain implants market. Increasing awareness and reducing the cost of manufacturing of brain implants by new developments are some opportunities for the players to increase target market. In addition, factors such as technological advancements in brain implants, along with rising disposable income in developed countries, are propelling global market growth. The market is expected to witness lucrative growth over the coming years as a consequence of increasing number of research activities leading to technological breakthroughs. These include self-charging implants and memory chips, which are estimated to unfold tremendous growth opportunities over the forecast period. High adoption of robot assistance for the brain surgeries by the surgeons for precision is one of the major trends that are expected to be observed during the forecast period. 

Global Brain Implants Market By Segmentations & Regional Insights

                                       

brain transplant market is segmented into product type, application and regions.

Based on product type, the global market is divided into deep brain stimulator, spinal cord stimulator and others. On the basis of application, the target market is segmented into chronic pain, epilepsy, Parkinson’s disease, and others.

Regional Insights:                                   

For detailed understanding of market dynamics, the global brain implants market is analysed across key regions viz North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each of these regions is analysed on the basis of market findings across major countries in these regions for a macro-level understanding of the global market. The market in North America is dominating the global brain implants market and is expected to continue its dominance over the forecast period. Due to increasing prevalence of several neurological disorders such as Parkinson’s disease, Alzheimer’s disease, epilepsy, and others, increase in market revenue in this region is expected to increase over the forecast period. Increasing investment in research and development activities and rise in technological advancement in brain implants devices are expected to drive revenue growth of the Europe brain implants market over the forecast period.

                                     

Attribut

Details

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Billion & CAGR from 2024 – 2034

Market Segmentation

By Product Type: Deep Brain Stimulator, Spinal Cord Stimulator, and Others

By Application: Chronic Pain, Epilepsy, Parkinson’s Disease, and Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Detailed Segmentation:

Brain Implants Market, By Product Type:

  • Brain Stimulator
  • Spinal Cord Stimulator
  • Vagus Nerve Stimulators

Brain Implants Market, By Application:

  • Chronic Pain
  • Epilepsy
  • Parkinson’s Disease
  • Others (Depression, Essential Tremor, and Alzheimer’s Disease)

Brain Implants Market, By Region:                                                                                                 

  • North America
    • North America Brain Implants Market, By Product Type
    • North America Brain Implants Market, By Application
    • North America Brain Implants Market, By Country
      • U.S.
      • Canada
  • Europe
    • Europe Brain Implants Market, By Product Type
    • Europe Brain Implants Market, By Application
    • Europe Brain Implants Market, By Country
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • Asia Pacific
    • Asia Pacific Brain Implants Market, By Product Type
    • Asia Pacific Brain Implants Market, By Application
    • Asia Pacific Brain Implants Market, By Country
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific 
  • Latin America
    • Latin America Brain Implants Market, By Product Type
    • Latin America Brain Implants Market, By Application
    • Latin America Brain Implants Market, By Country
      • Brazil
      • Mexico
      • Rest of Latin America
  • Middle East & Africa
    • Middle East & Africa Brain Implants Market, By Product Type
    • Middle East & Africa Brain Implants Market, By Application
    • Middle East & Africa Brain Implants Market, By Country
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa

Global Brain Implants Market By Competitive Landscape & Key Players

                                                                            

Some of the prominent players operating in the global brain implants market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Plc., Nevro Corp., Terumo Corporation, Aleva Neurotherapeutics SA, NDI Medical, LLC, LivaNova, PLC, NeuroPace, Inc., and Synchron, Inc. These key players in this market are focusing on increasing their presence through mergers & acquisitions and new product developments, specific to consumer tastes around the world. For instance, in 2016, Aleva Neurotherapeutics and Greatbatch, Inc. collaborated on Next Generation Device for Deep Brain Stimulation (DBS)

Global Brain Implants Market By Company Profile

  • Abbott Laboratories
    • Company Overview 
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Boston Scientific Corporation
    • Company Overview 
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Medtronic, Plc.
    • Company Overview 
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Nevro Corp.
    • Company Overview 
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Terumo Corporation
    • Company Overview 
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Aleva Neurotherapeutics SA
    • Company Overview 
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • NDI Medical, LLC
    • Company Overview 
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  •  LivaNova, PLC
    • Company Overview 
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • NeuroPace, Inc.
    • Company Overview 
    • Product Portfolio
    • Key Highlights
    • Financial Performance
  • Synchron, Inc.
    • Company Overview 
    • Product Portfolio
    • Key Highlights
    • Financial Performance

FAQs

Brain implant Market is segmented on the basis of product type, application and region.

Factor driving growth of the global brain implants market is high prevalence of neurological disorders such as Parkinson’s and Alzheimer’s diseases, epilepsy, depression, and essential tremor among all age groups across the globe.

North America is estimated to hold dominating position in the Brain Implant Market during the forecast period.

Some of the prominent players operating in the global brain implants market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Plc., Nevro Corp., Terumo Corporation, Aleva Neurotherapeutics SA, NDI Medical, LLC, LivaNova, PLC, NeuroPace, Inc., and Synchron, Inc.